ArticleDrug delivery2018

Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer.

Shan-Shan Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.